Determination of gene copy number status in tert and terc among chronic myeloid leukaemia patients resist ant and responsive to imatinib mesylate treatment
The frontline treatment of chronic phase (CP) chronic myeloid leukaemia (CML) patients is the use of Imatinib Mesylate (IM). A remarkable CP CML (1/3) patients failed to achieve any degree of good response towards IM treatment. Cancer cells express a higher telomerase activity compared to normal cel...
| Auteur principal: | |
|---|---|
| Format: | Thèse |
| Langue: | anglais |
| Publié: |
2014
|
| Sujets: | |
| Accès en ligne: | http://eprints.usm.my/62588/ |